May 26, 2025

Integer Holdings Corporation (ITGR) Stock Analysis: Evaluating a 25.73% Potential Upside in Medical Devices

For investors seeking opportunities in the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) offers a compelling case with its solid position in the medical device industry. With a market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: A Promising 56.7% Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology sector, offers a compelling opportunity for investors looking to capitalize on the burgeoning field of cancer diagnostics and research...

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 44% Potential Upside in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a leading name in the biotechnology sector, presents a compelling investment opportunity with a notable potential upside of 44.42%. Headquartered in Ramsey, New Jersey, ADMA..

Haleon plc (HLN) Stock Analysis: Navigating the Healthcare Landscape with a $50 Billion Market Cap

Haleon plc (HLN) stands as a formidable player in the healthcare sector, specializing in the development and sale of consumer healthcare products. Based in Weybridge, United Kingdom, the company boasts..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 51.99% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is garnering significant attention among investors, boasting a promising potential upside of 51.99%. Headquartered in Cambridge, Massachusetts, Nuvalent operates within the healthcare..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth in the Pharmaceutical Sector

Dr. Reddy’s Laboratories Ltd (RDY), a prominent player in the healthcare sector, is making waves in the pharmaceutical industry with its diverse portfolio and solid growth metrics. Headquartered in Hyderabad,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unpacking the 64% Potential Upside for Investors

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing the attention of investors with a promising upside potential of 64.37%. Specializing in the healthcare sector, specifically within the biotechnology industry, Akero Therapeutics..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Deep Dive into 49.14% Potential Upside

In the dynamic world of medical devices, Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out with its innovative approach to treating obstructive sleep apnea (OSA). This U.S.-based company, headquartered in..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 34.83% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), based in Dublin, Ireland, is a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of..

TG Therapeutics (TGTX) Stock Analysis: Exploring a 19% Upside in the Biotech Sector

TG Therapeutics, Inc. (TGTX), a biopharmaceutical company based in Morrisville, North Carolina, is gaining traction in the healthcare sector, particularly within the biotechnology industry. With a market cap of $5.49..

Exact Sciences Corporation (EXAS) Stock Analysis: Exploring a 20.86% Potential Upside in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with a robust potential upside of 20.86%. Specializing in..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Strong Analyst Support Despite High Valuation Challenges

iRhythm Technologies, Inc. (NASDAQ: IRTC), a key player in the medical devices industry, continues to make significant strides in the healthcare sector. Specializing in ambulatory cardiac monitoring services, iRhythm has..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking the 140% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK) is generating significant buzz in the biotech sector, captivating investor attention with a staggering 140.50% potential upside, as reflected in its average target price. With a..

IDEXX Laboratories, Inc. (IDXX) Stock Report: Navigating Growth in the Diagnostics & Research Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading player in the healthcare sector, is renowned for its innovative contributions to the diagnostics and research industry. With a market capitalization of $40.34..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 82% Upside Potential in Targeted Cancer Therapies

Revolution Medicines, Inc. (NASDAQ: RVMD) emerges as a compelling opportunity for investors keen on ventures at the forefront of oncology. Specializing in precision medicine, this biotech firm is charting a..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Promising Growth Potential

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotechnology industry, specializing in developing breakthrough cancer therapies. With a market capitalization of $11.56 billion, this U.S.-based oncology company..

CVS Health Corporation (CVS) Investor Outlook: Unpacking a 30% Upside Potential

CVS Health Corporation (CVS), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and promising potential for upside. With a market capitalization of..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Potential 31.63% Upside with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has emerged as a dynamic player in the biotechnology sector, captivating investor interest with its strategic focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: 26% Potential Upside and Strong Buy Ratings Spark Investor Interest

GE HealthCare Technologies Inc. (GEHC) stands as a significant player in the healthcare industry, particularly within the health information services sector. With a market capitalization of $31.67 billion, this U.S.-based..

The Cooper Companies, Inc. (COO): Investor Outlook with 33.90% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a significant player in the healthcare sector, specifically in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking exposure to..

Search

Funds

May 26, 2025

Search

Funds

May 26, 2025

FTSE 100

Funds